Parathyroid gland volume more than halved in patients treated with cinacalcet for 8 years.
Using cinacalcet in combination with other therapies may be even more efficacious, according to results from a new review.
Findings from a small study suggest that patients on peritoneal dialysis who have hungry bone syndrome respond better to treatment than those on hemodialysis.
Study supports the hypothesis that altered tubular phosphate handling drives the increase in serum phosphate during SGLT2 inhibition.
In a study, having the single nucleotide polymorphism rs11063112 in fibroblast growth factor 23 was associated with a 32% greater risk for cardiovascular mortality.
In a study of hemodialysis patients, vitamin D users had a lower mortality rate than nonusers: 9 vs 13 per 100 person-years.
Younger age, longer dialysis vintage, and black race are associated with greater cinacalcet prescribing in the United States.
Hyperkalemia developed in nearly 67% of hemodialysis patients during or immediately following total parathyroidectomy with autotransplantation for secondary hyperparathyroidism.
In a small study, more than half of pediatric patients receiving cinacalcet experienced a 30% or greater decline in mean intact parathyroid hormone.
Patients who underwent subtotal vs total parathyroidectomy had half the risk for cardiovascular events.
In a small study of hemodialysis patients with secondary hyperparathyroidism, abdominal aortic calcification decreased more in patients who underwent parathyroidectomy than in those in a control group over 1 year.
Trial results do not support use of vitamin D receptor activators to prevent cardiovascular events in patients with end-stage renal disease and low intact parathyroid hormone levels.
Markers of bone resorption decreased in hemodialysis patients with 6 months of etelcalcetide treatment.
Analyses demonstrated that an ABI of 1.79 correlated with radiographic evidence of calcified vessels.
In a study, patients receiving cinacalcet under supervision 3 times per week after dialysis rather than after daily self-administration showed improvement in their parathyroid hormone levels.
In a study, patients with uncontrolled SHPT were switched from oral cinacalcet to intravenous etelcalcetide.
Loss of renal function may not be the sole factor in SHPT development, according to new study findings.
According to a study, black youth on dialysis have higher parathyroid hormone levels than white youth.
In a case series of 10 pediatric patients, goal iPTH was attained over a median 6 months.
Despite promising early research, the vitamin C did not improve mineral abnormalities over the long term.
In a study, patients with hypercalcemia had the highest risk for premature death.
Secondary hyperparathyroidism in postmenopausal women with vitamin D insufficiency is associated with lower weight-adjusted bone mineral density in the lumbar spine.
In a small study, total parathyroidectomy without autotransplantation improved bone mineral density in the lumbar spine and hip in ESRD patients with secondary hyperparathyroidism.
Researchers examined the effects of the end of public funding for the medication in Australia.
Obese or overweight individuals have significantly lower levels of 25-hydroxyvitamin D than normal-weight individuals at any level of kidney function, a study found.
Surgical procedure can correct calcium and phosphorus abnormalities and improve coronary artery calcification, study finds.
Protein-energy wasting is characterized by undernutrition unrelieved by nutritional therapy and increased fat and protein catabolism.
Serum parathyroid hormone levels significantly increased from 42.2 to 114.8 pmol/L over 12 months in patients who halted the calcimimetic drug.
Pre-operative parathyroid hormone and calcium levels and pruritus are significantly associated with development of severe hypocalemia.
Anemia control may be one more reason to treat elevated parathyroid hormone levels.
Renal and Urology News Articles
- Obesity Linked With Improved Survival in mCRPC
- Radium-223 Use in mCRPC Differs By Race
- Brachytherapy for Favorable-Risk Prostate Cancer Continues to Decline
- Kidney Damage in Younger Adults Tied to NSAID Use
- Abiraterone, Prednisone With Androgen Deprivation Therapy Show Durable Efficacy in Metastatic Castration-Naive Prostate Cancer
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)